Dr. Kristianne Hannemann, PharmD

Dr. Kristianne Hannemann is a licensed pharmacist with over seven years of experience in community pharmacy and patient education. She specializes in medical writing and drug information. Dr. Hannemann is passionate about delivering current, evidence-based medication information in a clear, accessible format, empowering patients to confidently navigate their health journey.

Title Role : Licensed Pharmacist

Education Qualifications :

Specialties area o interest : Drug Information

Work Experience :

Editorial pharmacist at Drugs.com, providing accurate, up-to-date, and unbiased information about medications to a wide range of audiences, including healthcare professionals, patients, and organizations. Freelance medical writer delieving articles and drug information updates for healthcare companies such as GoodRx.com

Recent Review Blogs

20Mar, 2026

Diabetic Shock vs Insulin Shock: Symptoms, Causes & 15-Second Treatment

March 20, 2026|

Diabetic shock is a state of severe low blood sugar, known medically as hypoglycemia, that occurs when blood glucose levels plunge dangerously below the normal range. Insulin shock is an older medical term that describes the exact same condition. Both terms refer to severe hypoglycemia a medical emergency in which the brain and body do [...]

20Mar, 2026

What Organ Produces Insulin? Beta Cells + Ozempic Connection 2026

March 20, 2026|

The pancreas produces insulin. This large gland, located behind the stomach, serves as both a digestive and endocrine organ. Its endocrine portion making up roughly 1-3% of the organ’s total volume contains clusters of hormone-secreting cells called the islets of Langerhans.  Within these islets, beta cells are the insulin-producing cells responsible for synthesizing, storing, and [...]

20Mar, 2026

Why Sliding Scale Insulin is Fading in Long-Term Care?

March 20, 2026|

Sliding scale insulin is fading in long-term care because it is a purely reactive approach that treats hyperglycemia after it happens rather than preventing it. This correction-only method doses short-acting insulin based on a patient’s current blood glucose readingtypically before meals and at bedtimewithout providing any baseline (basal) insulin coverage throughout the day.  The result [...]

13Mar, 2026

Ozempic Cost 2026: Canada vs USA Price Comparison Guide

March 13, 2026|

Ozempic costs roughly $1,029 per month at US retail pharmacies, but most people never pay that full amount. Your actual out-of-pocket cost depends on your health insurance plan, pharmacy, dose and whether you qualify for manufacturer savings programs.  In Canada, the same medication is available for significantly less. Pandameds.com offers Ozempic at $379.99 per month [...]

3Mar, 2026

Can Americans legally buy prescription drugs from Canada

March 3, 2026|

In most circumstances, it is illegal for Americans to import prescription drugs from another country, including Canada. The Federal Food, Drug, and Cosmetic Act (FD&C Act) prohibits the importation of unapproved drugs into the United States, and the FDA generally enforces this prohibition. However, the practical reality in 2026 is more nuanced: the FDA exercises [...]

27Feb, 2026

Victoza vs Mounjaro 2026: Mounjaro 22.5% Weight Loss vs Victoza ~3% – Complete Comparison

February 27, 2026|

Mounjaro dominates Victoza for weight loss: up to 22.5% of body weight versus approximately 3%, weekly dosing versus daily, and a dual GLP-1/GIP mechanism versus single GLP-1 action. Both are injectable medications prescribed to treat diabetes and help regulate blood sugar levels, but Mounjaro was engineered from the ground up for superior metabolic outcomes in [...]

27Feb, 2026

Saxenda vs Mounjaro: Mounjaro 22.5% Loss vs Saxenda 8% – Head-to-Head Analysis

February 27, 2026|

Mounjaro dominates Saxenda across every major metric: 22.5% body weight loss vs 8%, once-weekly injection vs daily injection, and dual GLP-1/GIP mechanism vs single GLP-1. Both Saxenda and Mounjaro are prescription medications designed to support weight management by reducing appetite and helping patients lose weight when combined with lifestyle changes. However, clinical trial data shows [...]

21Feb, 2026

Rybelsus vs Januvia: Oral GLP-1 vs DPP4 Comparison (Weight Loss, A1C, Cost)

February 21, 2026|

Rybelsus and Januvia are two widely prescribed oral medications for adults with type 2 diabetes, but they belong to fundamentally different drug classes.  Rybelsus (oral semaglutide), manufactured by Novo Nordisk, is a GLP-1 receptor agonist the first of its kind available as an oral tablet rather than an injection.  Januvia (sitagliptin), produced by Merck, is [...]

21Feb, 2026

Trulicity Cost: $987 Monthly Without Insurance + Savings Guide

February 21, 2026|

Trulicity is a brand-name GLP-1 receptor agonist manufactured by Eli Lilly and prescribed primarily for managing type 2 diabetes. Because no generic version exists, out-of-pocket expenses can be steep. The cost of Trulicity depends on a few factors: your insurance plan, dosage, pharmacy location, and whether you qualify for manufacturer savings programs or patient assistance [...]

21Feb, 2026

Rybelsus vs Metformin: Oral GLP-1 vs Biguanide Comparison (Weight Loss, A1C, Cost)

February 21, 2026|

Rybelsus and metformin are both prescription medications used to lower blood sugar levels in adults with type 2 diabetes, but these two diabetes medications work differently and belong to separate drug classes. Rybelsus is a brand-name oral GLP-1 receptor agonist containing the active ingredient semaglutide. It works by mimicking the hormone GLP-1 to increase insulin [...]

20Feb, 2026

Farxiga vs Ozempic: SGLT2 vs GLP-1 Comparison (Weight Loss, A1C, Cost)

February 20, 2026|

Dapagliflozin (Farxiga) and semaglutide (Ozempic) are both medications used to treat type 2 diabetes, yet they work through entirely different pharmacological pathways.  Farxiga is an SGLT2 inhibitor an oral medication that lowers blood glucose levels by blocking glucose reabsorption in the kidneys, causing sugar to be eliminated through urine.  Ozempic is a GLP-1 receptor agonist [...]

20Feb, 2026

Saxenda Cost 2026: $1,349 Monthly Without Insurance + $25 Savings Guide

February 20, 2026|

The list price for Saxenda (liraglutide) is $1,349.02 for a 30-day supply, which includes five 3mL prefilled injectable pens. Saxenda is an FDA-approved GLP-1 receptor agonist prescription medication designed to help adults with obesity or overweight with weight-related medical conditions lose weight and maintain weight loss when used with a reduced calorie diet and increased [...]

20Feb, 2026

Zepbound Cost: $1,086 Monthly List + $25 Copay Savings Guide

February 20, 2026|

According to Lilly's official pricing information, the list price of Zepbound is $1,086 per month for a 28-day supply (4 pre-filled pens). This applies to all dosage strengths from 2.5 mg to 15 mg. However, your actual monthly costs depend on insurance coverage, discount eligibility, and how you access care.  The medication is administered as [...]

20Feb, 2026

Metformin vs Ozempic: Weight Loss + Combination Therapy

February 20, 2026|

Metformin has been a cornerstone of type 2 diabetes treatment for over five decades, recommended by the American Diabetes Association as a first-line treatment alongside lifestyle changes. Ozempic (semaglutide), approved by the FDA in 2017, represents the newer class of GLP-1 receptor agonists that have transformed diabetes care and weight management. The key differences between [...]

20Feb, 2026

Does Ozempic Lower Blood Sugar & Pressure?

February 20, 2026|

Ozempic (semaglutide) is an injectable GLP-1 receptor agonist that the Food and Drug Administration (FDA) approved to improve blood sugar levels in adults with type 2 diabetes. Beyond blood sugar management, research suggests that Ozempic also lowers blood pressure. A 2023 systematic review and meta-analysis published in the Journal of Clinical Medicine found that semaglutide [...]

20Feb, 2026

Tirzepatide vs Semaglutide: Dual GIP/GLP-1 vs GLP-1 (Weight Loss, A1C, Cost)

February 20, 2026|

Tirzepatide outperforms semaglutide for weight loss and blood sugar control in most clinical settings. In the landmark SURPASS-2 trial published in the New England Journal of Medicine, tirzepatide at its highest dose (15 mg) achieved roughly double the weight reduction of semaglutide 1 mg at 40 weeks. For chronic weight management in adults with obesity, [...]

20Feb, 2026

Trulicity Coupon 2026: $25 Savings Card, Copay, Discounts Guide

February 20, 2026|

As of early 2026, the average retail price of Trulicity without insurance is approximately $1,395.75 for four Trulicity pens a standard 30-day supply. The good news: several savings programs exist to help eligible patients dramatically reduce what they pay out of pocket. The most significant is the official Trulicity Savings Card from Eli Lilly, which [...]

20Feb, 2026

Does Metformin Cause Diarrhea? Management Guide (Causes, Foods, Alternatives)

February 20, 2026|

Yes, metformin can cause diarrhea and it is the most frequently reported gastrointestinal side effect of the drug. Gastrointestinal side effects occur in up to 75% of people who take metformin, with diarrhea leading the list (PMC   Common Drug, Common Side Effect, Uncommon Time). Metformin remains the first-line medication recommended by the American Diabetes [...]

20Feb, 2026

Metformin Dosage: Charts, Weight Loss, Max Dose, Starting Guide

February 20, 2026|

Metformin hydrochloride is the preferred first-line medication for managing blood sugar control in adults with type 2 diabetes, according to the American Diabetes Association (ADA) Standards of Care.  As an active drug in the biguanide class, metformin works by reducing hepatic glucose production, improving insulin sensitivity in peripheral tissues, and lowering blood glucose levels without [...]

Go to Top
X